- Home
- SNTI vs FMST Comparison
SNTI vs FMST Comparison
Compare SNTI & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- FMST
- Stock Information
- Founded
- SNTI 2016
- FMST 2005
- Country
- SNTI United States
- FMST Canada
- Employees
- SNTI N/A
- FMST N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- SNTI Health Care
- FMST Basic Materials
- Exchange
- SNTI Nasdaq
- FMST Nasdaq
- Market Cap
- SNTI 39.6M
- FMST 38.2M
- IPO Year
- SNTI N/A
- FMST N/A
- Fundamental
- Price
- SNTI $1.78
- FMST $3.57
- Analyst Decision
- SNTI Strong Buy
- FMST
- Analyst Count
- SNTI 2
- FMST 0
- Target Price
- SNTI $8.50
- FMST N/A
- AVG Volume (30 Days)
- SNTI 139.1K
- FMST 525.2K
- Earning Date
- SNTI 11-13-2025
- FMST 11-21-2025
- Dividend Yield
- SNTI N/A
- FMST N/A
- EPS Growth
- SNTI N/A
- FMST N/A
- EPS
- SNTI N/A
- FMST N/A
- Revenue
- SNTI N/A
- FMST N/A
- Revenue This Year
- SNTI N/A
- FMST N/A
- Revenue Next Year
- SNTI $150.00
- FMST N/A
- P/E Ratio
- SNTI N/A
- FMST N/A
- Revenue Growth
- SNTI N/A
- FMST N/A
- 52 Week Low
- SNTI $1.26
- FMST $0.55
- 52 Week High
- SNTI $16.94
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- SNTI 73.44
- FMST 64.72
- Support Level
- SNTI $1.36
- FMST $2.94
- Resistance Level
- SNTI $1.75
- FMST $3.17
- Average True Range (ATR)
- SNTI 0.08
- FMST 0.25
- MACD
- SNTI 0.05
- FMST 0.06
- Stochastic Oscillator
- SNTI 95.45
- FMST 85.21
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.